Sfoglia per Autore
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study
2006-01-01 R., Murri; A., COZZI LEPRI; P., Cicconi; A., Poggio; M., Arlotti; G., Tositti; D., Santoro; Ml, Doranzo; G., Rizzardini; V., Colangeli; Montroni, Maria
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio
2006-01-01 Costantini, Andrea; Giuliodoro, S; Mancini, S; Butini, L; Regnery, C. M.; Silvestri, G; Greco, F; Leoni, Pietro; Montroni, Maria
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche.
2007-01-01 Montroni, Maria; Bartocci, C; Costantini, Andrea
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
2008-01-01 Fox, Z; Phillips, A; Cohen, C; Neuhaus, J; Baxter, J; Emery, S; Hirschel, B; Hullsiek, Kh; Stephan, C; Lundgren, J; SMART STUDY, Group; Montroni, Maria
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis.
2008-01-01 Cicconi, P; COZZI LEPRI, A; Orlando, G; Matteelli, A; Girardi, E; DEGLI ESPOSTI, A; Moioli, C; Rizzardini, G; Chiodera, A; Ballardini, G; Tincati, C; D'ARMINIO MONFORTE, A; STUDY GROUP, I. C. O. N. A.; Montroni, Maria
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
2008-01-01 ANTIRETROVIRAL THERAPY COHORT COLLABORATION ART, Cc; Mugavero, Mj; May, M; Harris, R; Saag, Ms; Costagliola, D; Egger, M; Phillips, A; Günthard, Hf; Dabis, F; Hogg, R; DE WOLF, F; Fatkenheuer, G; Gill, Mj; Justice, A; D'ARMINIO MONFORTE, A; Lampe, F; Miró, Jm; Staszewski, S; Montroni, Maria
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.
2008-01-01 ZANONE POMA, B; Riva, A; Nasi, M; Cicconi, P; Broggini, V; Lepri, Ac; Mologni, D; Mazzotta, F; Monforte, Ad; Mussini, C; Cossarizza, A; Galli, M; ICONA FOUNDATION STUDY, Group; Montroni, Maria
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
2008-01-01 Monforte, A; Abrams, D; Pradier, C; Weber, R; Reiss, P; Bonnet, F; Kirk, O; Law, M; DE WIT, S; FRIIS MØLLER, N; Phillips, An; Sabin, Ca; Lundgren, Jd; DATA COLLECTION ON ADVERSE EVENTS OF ANTI HIV DRUGS DAD STUDY, Group; Montroni, Maria
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
2008-01-01 STRATEGIES FOR MANAGEMENT OF ANTIRETROVIRAL THERAPY SMART STUDY, Group; Lundgren, Jd; Babiker, A; EL SADR, W; Emery, S; Grund, B; Neaton, Jd; Neuhaus, J; Montroni, Maria
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.
2008-01-01 DATA COLLECTION ON ADVERSE EVENTS OF ANTI HIV DRUGS STUDY, Group; Sabin, Ca; D'ARMINIO MONFORTE, A; FRIIS MOLLER, N; Weber, R; EL SADR, Wm; Reiss, P; Kirk, O; Mercie, P; Law, Mg; DE WIT, S; Pradier, C; Phillips, An; Montroni, Maria
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
2008-01-01 SMART STUDY, Group; EL SADR, Wm; Grund, B; Neuhaus, J; Babiker, A; Cohen, Cj; Darbyshire, J; Emery, S; Lundgren, Jd; Phillips, A; Montroni, Maria
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
2008-01-01 DAD STUDY, Group; Sabin, Ca; Worm, Sw; Weber, R; Reiss, P; EL SADR, W; Dabis, F; DE WIT, S; Law, M; D'ARMINIO MONFORTE, A; FRIIS MØLLER, N; Kirk, O; Pradier, C; Weller, I; Phillips, An; Montroni, Maria
Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study.
2008-01-01 STRATEGIES FOR MANAGEMENT OF ANTIRETROVIRAL THERAPY SMART STUDY, Group; Emery, S; Neuhaus, Ja; Phillips, An; Babiker, A; Cohen, Cj; Gatell, Jm; Girard, Pm; Grund, B; Law, M; Losso, Mh; Palfreeman, A; Montroni, Maria
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
2008-01-01 Saracino, A; Gianotti, N; Marangi, M; Cibelli, Dc; Galli, A; Punzi, G; Monno, L; Lazzarin, A; Angarano, G; Mutations, ; SALVAGE STUDY, Group; Montroni, Maria
Lo studio fenotipico di linfociti e altre cellule mononucleate.
2008-01-01 Montroni, Maria; Bartocci, C; Costantino, E; Massaccesi, C; Costantini, Andrea
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.
2009-01-01 Podlekareva, Dn; Mocroft, A; Post, Fa; Riekstina, V; Miro, Jm; Furrer, H; Bruyand, M; Panteleev, Am; Rakhmanova, Ag; Girardi, E; Losso, Mh; Toibaro, Jj; Caylá, J; Miller, Rf; Obel, N; Skrahina, A; Chentsova, N; Lundgren, Jd; Kirk, O; HIVTB STUDY WRITING, Group; Montroni, Maria
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
2009-01-01 ANTIRETROVIRAL THERAPY COHORT COLLABORATION ART, Cc; Mocroft, A; Sterne, Ja; Egger, M; May, M; Grabar, S; Furrer, H; Sabin, C; Fatkenheuer, G; Justice, A; Reiss, P; D'ARMINIO MONFORTE, A; Gill, J; Hogg, R; Bonnet, F; Kitahata, M; Staszewski, S; Casabona, J; Harris, R; Montroni, Maria
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
2009-01-01 Morsica, G; Bagaglio, S; Cicconi, P; Capobianchi, Mr; Pellizzer, G; Caramello, P; Orani, A; Moioli, C; Rizzardini, G; UBERTI FOPPA, C; Puoti, M; Monforte, Ad; HEPA I. C. O. N. A., THE ICONA FOUNDATION STUDY GROUPS; Montroni, Maria
Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
2009-01-01 Mocroft, A; Wyatt, C; Szczech, L; Neuhaus, J; EL SADR, W; Tracy, R; Kuller, L; Shlipak, M; Angus, B; Klinker, H; Ross, M; INSIGHT SMART STUDY, Group; Montroni, Maria
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study.
2009-01-01 DE WECK, Al; Sanz, Ml; Gamboa, Pm; Aberer, W; Sturm, G; Bilo, Mb; Montroni, Maria; Blanca, M; Torres, Mj; Mayorga, L; Campi, P; Manfredi, M; Drouet, M; SAINTE LAUDY, J; Romano, A; Merk, H; Weber, Jm; Jermann, Tm; AND MEMBERS OF ENDA EUROPEAN NETWORK FOR DRUG, Allergy
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study | 1-gen-2006 | R., Murri; A., COZZI LEPRI; P., Cicconi; A., Poggio; M., Arlotti; G., Tositti; D., Santoro; Ml, Doranzo; G., Rizzardini; V., Colangeli; Montroni, Maria | |
| Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio | 1-gen-2006 | Costantini, Andrea; Giuliodoro, S; Mancini, S; Butini, L; Regnery, C. M.; Silvestri, G; Greco, F; Leoni, Pietro; Montroni, Maria | |
| Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. | 1-gen-2007 | Montroni, Maria; Bartocci, C; Costantini, Andrea | |
| Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. | 1-gen-2008 | Fox, Z; Phillips, A; Cohen, C; Neuhaus, J; Baxter, J; Emery, S; Hirschel, B; Hullsiek, Kh; Stephan, C; Lundgren, J; SMART STUDY, Group; Montroni, Maria | |
| Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. | 1-gen-2008 | Cicconi, P; COZZI LEPRI, A; Orlando, G; Matteelli, A; Girardi, E; DEGLI ESPOSTI, A; Moioli, C; Rizzardini, G; Chiodera, A; Ballardini, G; Tincati, C; D'ARMINIO MONFORTE, A; STUDY GROUP, I. C. O. N. A.; Montroni, Maria | |
| Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? | 1-gen-2008 | ANTIRETROVIRAL THERAPY COHORT COLLABORATION ART, Cc; Mugavero, Mj; May, M; Harris, R; Saag, Ms; Costagliola, D; Egger, M; Phillips, A; Günthard, Hf; Dabis, F; Hogg, R; DE WOLF, F; Fatkenheuer, G; Gill, Mj; Justice, A; D'ARMINIO MONFORTE, A; Lampe, F; Miró, Jm; Staszewski, S; Montroni, Maria | |
| Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. | 1-gen-2008 | ZANONE POMA, B; Riva, A; Nasi, M; Cicconi, P; Broggini, V; Lepri, Ac; Mologni, D; Mazzotta, F; Monforte, Ad; Mussini, C; Cossarizza, A; Galli, M; ICONA FOUNDATION STUDY, Group; Montroni, Maria | |
| HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. | 1-gen-2008 | Monforte, A; Abrams, D; Pradier, C; Weber, R; Reiss, P; Bonnet, F; Kirk, O; Law, M; DE WIT, S; FRIIS MØLLER, N; Phillips, An; Sabin, Ca; Lundgren, Jd; DATA COLLECTION ON ADVERSE EVENTS OF ANTI HIV DRUGS DAD STUDY, Group; Montroni, Maria | |
| Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. | 1-gen-2008 | STRATEGIES FOR MANAGEMENT OF ANTIRETROVIRAL THERAPY SMART STUDY, Group; Lundgren, Jd; Babiker, A; EL SADR, W; Emery, S; Grund, B; Neaton, Jd; Neuhaus, J; Montroni, Maria | |
| Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. | 1-gen-2008 | DATA COLLECTION ON ADVERSE EVENTS OF ANTI HIV DRUGS STUDY, Group; Sabin, Ca; D'ARMINIO MONFORTE, A; FRIIS MOLLER, N; Weber, R; EL SADR, Wm; Reiss, P; Kirk, O; Mercie, P; Law, Mg; DE WIT, S; Pradier, C; Phillips, An; Montroni, Maria | |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. | 1-gen-2008 | SMART STUDY, Group; EL SADR, Wm; Grund, B; Neuhaus, J; Babiker, A; Cohen, Cj; Darbyshire, J; Emery, S; Lundgren, Jd; Phillips, A; Montroni, Maria | |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. | 1-gen-2008 | DAD STUDY, Group; Sabin, Ca; Worm, Sw; Weber, R; Reiss, P; EL SADR, W; Dabis, F; DE WIT, S; Law, M; D'ARMINIO MONFORTE, A; FRIIS MØLLER, N; Kirk, O; Pradier, C; Weller, I; Phillips, An; Montroni, Maria | |
| Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study. | 1-gen-2008 | STRATEGIES FOR MANAGEMENT OF ANTIRETROVIRAL THERAPY SMART STUDY, Group; Emery, S; Neuhaus, Ja; Phillips, An; Babiker, A; Cohen, Cj; Gatell, Jm; Girard, Pm; Grund, B; Law, M; Losso, Mh; Palfreeman, A; Montroni, Maria | |
| Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. | 1-gen-2008 | Saracino, A; Gianotti, N; Marangi, M; Cibelli, Dc; Galli, A; Punzi, G; Monno, L; Lazzarin, A; Angarano, G; Mutations, ; SALVAGE STUDY, Group; Montroni, Maria | |
| Lo studio fenotipico di linfociti e altre cellule mononucleate. | 1-gen-2008 | Montroni, Maria; Bartocci, C; Costantino, E; Massaccesi, C; Costantini, Andrea | |
| Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. | 1-gen-2009 | Podlekareva, Dn; Mocroft, A; Post, Fa; Riekstina, V; Miro, Jm; Furrer, H; Bruyand, M; Panteleev, Am; Rakhmanova, Ag; Girardi, E; Losso, Mh; Toibaro, Jj; Caylá, J; Miller, Rf; Obel, N; Skrahina, A; Chentsova, N; Lundgren, Jd; Kirk, O; HIVTB STUDY WRITING, Group; Montroni, Maria | |
| Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. | 1-gen-2009 | ANTIRETROVIRAL THERAPY COHORT COLLABORATION ART, Cc; Mocroft, A; Sterne, Ja; Egger, M; May, M; Grabar, S; Furrer, H; Sabin, C; Fatkenheuer, G; Justice, A; Reiss, P; D'ARMINIO MONFORTE, A; Gill, J; Hogg, R; Bonnet, F; Kitahata, M; Staszewski, S; Casabona, J; Harris, R; Montroni, Maria | |
| Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. | 1-gen-2009 | Morsica, G; Bagaglio, S; Cicconi, P; Capobianchi, Mr; Pellizzer, G; Caramello, P; Orani, A; Moioli, C; Rizzardini, G; UBERTI FOPPA, C; Puoti, M; Monforte, Ad; HEPA I. C. O. N. A., THE ICONA FOUNDATION STUDY GROUPS; Montroni, Maria | |
| Interruption of antiretroviral therapy is associated with increased plasma cystatin C. | 1-gen-2009 | Mocroft, A; Wyatt, C; Szczech, L; Neuhaus, J; EL SADR, W; Tracy, R; Kuller, L; Shlipak, M; Angus, B; Klinker, H; Ross, M; INSIGHT SMART STUDY, Group; Montroni, Maria | |
| Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. | 1-gen-2009 | DE WECK, Al; Sanz, Ml; Gamboa, Pm; Aberer, W; Sturm, G; Bilo, Mb; Montroni, Maria; Blanca, M; Torres, Mj; Mayorga, L; Campi, P; Manfredi, M; Drouet, M; SAINTE LAUDY, J; Romano, A; Merk, H; Weber, Jm; Jermann, Tm; AND MEMBERS OF ENDA EUROPEAN NETWORK FOR DRUG, Allergy |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile